Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
Showing 8,941 - 8,960 results of 32,204 for search '(( a step decrease ) OR ( 50 ((((nn decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 0.98s Refine Results
  1. 8941
    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects

    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

    Published 2023
    “…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC<sub>50</sub> values of 10<sup>–8</sup> M. …”
    Save to List
    Saved in:
  2. 8942
    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects

    Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

    Published 2023
    “…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC<sub>50</sub> values of 10<sup>–8</sup> M. …”
    Save to List
    Saved in:
  3. 8943
    Screening of either Higher Binding Affinity or Non-affinity scFv against Wild-type or Beta SARS-CoV-2.

    Screening of either Higher Binding Affinity or Non-affinity scFv against Wild-type or Beta SARS-CoV-2. by Ye Yang (297214)

    Published 2023
    Save to List
    Saved in:
  4. 8944
    S5 File -

    S5 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  5. 8945
    S3 File -

    S3 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  6. 8946
    S1 File -

    S1 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  7. 8947
    S6 File -

    S6 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  8. 8948
    S2 File -

    S2 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  9. 8949
    S4 File -

    S4 File - by Marian Adan (16641634)

    Published 2024
    Save to List
    Saved in:
  10. 8950
    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. …”
    Save to List
    Saved in:
  11. 8951
    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. …”
    Save to List
    Saved in:
  12. 8952
    Mesh partitioning results.

    Mesh partitioning results. by Hang Chen (23866)

    Published 2024
    Save to List
    Saved in:
  13. 8953
    GM Mask image count after preprocessing.

    GM Mask image count after preprocessing. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  14. 8954
    Architecture of Multi-EfficientNet.

    Architecture of Multi-EfficientNet. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  15. 8955
    Average Saliency Map Results.

    Average Saliency Map Results. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  16. 8956
    Original dataset composition (Raw from ADNI).

    Original dataset composition (Raw from ADNI). by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  17. 8957
    Class-wise performance on the test set.

    Class-wise performance on the test set. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  18. 8958
    Details of Hyperparameters.

    Details of Hyperparameters. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:
  19. 8959
    <i>N</i>. <i>bombycis</i> coated with BmVg in infected ovarioles.

    <i>N</i>. <i>bombycis</i> coated with BmVg in infected ovarioles. by Chunxia Wang (766713)

    Published 2023
    Save to List
    Saved in:
  20. 8960
    Ablation Study Result.

    Ablation Study Result. by Muhammad Zubair (728141)

    Published 2025
    Save to List
    Saved in:

Search Tools: